Understanding how people use continuous glucose monitors
Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study asks people with diabetes to use a continuous glucose monitor (a small device that tracks blood sugar automatically) and share their thoughts about it. Researchers want to understand what features matter most to patients and how well the device works in real life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or older
- Diagnosed with type 1 diabetes, type 2 diabetes, or gestational diabetes
- Own a smartphone with internet and Bluetooth access for the entire study
- Currently taking diabetes medication (if using insulin, must be on it for at least 3 months)
- No severe diabetes complications like eye damage or diabetic emergencies
- Not hospitalized in the past 3 months for severe blood-sugar crises
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new continuous glucose monitor that checks your blood sugar levels in real time. It aims to see how accurate and safe it is for people with diabetes.
This trial tests a new continuous glucose monitor that checks blood sugar levels without frequent finger pricks. It aims to see how accurate and safe it is for people with type 1 diabetes.
This study tests whether using a continuous glucose monitor (CGM) helps people who were just diagnosed with type 2 diabetes manage their blood sugar better. Participants wear a small sensor on their arm that checks sugar levels all the time.
This study gives continuous glucose monitors (CGMs) to people with type 2 diabetes who cannot afford them. It looks at whether using a CGM helps improve blood sugar control.
This study checks whether using a continuous glucose monitor (CGM, a sensor that tracks blood sugar) is practical and helpful for people with type 2 diabetes in primary care settings. It focuses on people who may have a harder time getting diabetes support and have higher A1c levels.
This trial looks at the experiences of people with type 2 diabetes who have used a continuous glucose monitor (CGM) for at least a year and are on intensive insulin therapy. The goal is to learn how CGM helps manage their condition.
Hear when a new Type2diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.